Healthcare -
Biotechnology - NASDAQ - US
$ 59.58
-3.9 %
$ 11.4 B
Market Cap
22.09
P/E
BMRN - REVENUE
Revenue BMRN - BioMarin Pharmaceutical Inc.
2.85 B
LAST VALUE
16.69%
2 YEAR CAGR
10.86%
5 YEAR CAGR
14.28%
10 YEAR CAGR